Bay Adelaide Centre - West Tower
333 Bay Street, Suite 3400
Toronto, ON M5H 2S7
Rick Tuzi is a consultant in Litigation Group at Goodmans. His practice focuses on intellectual property rights litigation with a particular emphasis on pharmaceutical patent litigation, including proceedings under the Patented Medicines (Notice of Compliance) Regulations.
He has worked on intellectual property cases before the Federal Court and the Trade-marks Opposition Board. His efforts in these matters have been directed to representing generic pharmaceutical companies and have led to several patnts being deemed invalid by the Federal Court of Canada.
As a former synthetic organic chemist and a current registered trade-mark agent, Rick brings relevant industry experience and perspective to his clients.
Rick’s representative work includes:
- Pfizer v. Apotex (desvenlafaxine)
- Endo Ventures v. Apotex (tapentadol)
- Bayer v. Apotex (drospirenone)
- Amgen v. Apotex (filgrastim)
- Sanofi Aventis v. Apotex (ramipril)
- Astra Zeneca v. Apotex (omeprazole)
- Galderma v. Apotex (doxycycline)
- Pfizer v. Apotex (quinapril)
- Eli Lilly v Teva (pemetrexed)
- Janssen v Teva (bortezomib)
|Education|| University of Western Ontario (LL.B., 1997)
York University (B.Sc., Honours, 1991)
Law Society of Ontario